Literature DB >> 4372815

Expression of Epstein-Barr viral capsid, complement fixing, and nuclear antigens in stationary and exponential phase cultures.

G Miller, L Heston.   

Abstract

Three continuous lymphoblastoid cell lines, 2 productive of nucleocapsids and 1 nonproductive line, were studied for their content of Epstein-Barr viral (EBV) antigens during transition from stationary to logarithmic phase growth. As a preliminary step, viable cells were separated from degenerating ones in discontinuous gradients of serum albumin. Viral capsid antigens were found in both living and dead cells of the 2 producer lines; however, complement fixing (CF) antigens and nuclear antigen were detected only in viable cell subpopulations. The content of antigen detectable in extracts of viable cells by complement fixation remained constant in replicating and resting cultures; further, all viable cells of the 3 lines demonstrated intranuclear antigen by anticomplement immunofluorescence in all stages of growth. In contrast, the proportion of cells with viral capsid antigen in the producer lines increased 7- to 24-fold following entry of resting populations into the phase of exponential growth.The results suggest that expression of viral capsid antigens is discontinuous and is initiated in response to events in log phase, possibly DNA synthesis or mitosis. Expression of the complement fixing and nuclear antigens in continuous in viable cells. These findings emphasize the intimate relationship of the CF and nuclear antigen to the transformed state and suggest that study of this antigen complex will shed light on the mechanisms of lymphocyte transformation by EBV.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4372815      PMCID: PMC2596417     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  26 in total

1.  VIRAL LEUKOCYTE INTERRELATIONSHIPS. I. MULTIPLICATION OF A DNA VIRUS--HERPES SIMPLEX--IN HUMAN LEUKOCYTE CULTURES.

Authors:  A J JAHMIAS; S KIBRICK; R C ROSAN
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

2.  Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine.

Authors:  J G Derge; L M Martos; M A Tagamets; S Y Chang; M Chakrabarty
Journal:  Nat New Biol       Date:  1973-08-15

3.  Detection of Epstein-Barr viral genome in nonproductive cells.

Authors:  M Nonoyama; J S Pagano
Journal:  Nat New Biol       Date:  1971-09-22

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  Epstein-Barr virus antigens, marker chromosome, and interferon production in clones derived from cultured Burkitt tumor cells.

Authors:  B A Zajac; G Kohn
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

6.  Epstein-Barr virus-induced viral and soluble complement-fixing antigens in Burkitt lymphoma cell cultures.

Authors:  P Gerber; D R Deal
Journal:  Proc Soc Exp Biol Med       Date:  1970-07

7.  Studies of the EB virus-related antigens of human leukocyte cell lines.

Authors:  M K Walters; J H Pope
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

8.  Fluorescent antibody detection of the antigens of the Shope papilloma virus in papillomas of the wild and domestic rabbit.

Authors:  W F NOYES; R C MELLORS
Journal:  J Exp Med       Date:  1957-10-01       Impact factor: 14.307

9.  MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA.

Authors:  M A EPSTEIN; G HENLE; B G ACHONG; Y M BARR
Journal:  J Exp Med       Date:  1965-05-01       Impact factor: 14.307

10.  Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.

Authors:  G Miller; M Lipman
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.